These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3053904)
1. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human beta 2-microglobulin. Taurog JD; Lowen L; Forman J; Hammer RE J Immunol; 1988 Dec; 141(11):4020-3. PubMed ID: 3053904 [TBL] [Abstract][Full Text] [Related]
2. Cell-surface expression and alloantigenic function of a human nonclassical class I molecule (HLA-E) in transgenic mice. Pacasova R; Martinozzi S; Boulouis HJ; Ulbrecht M; Vieville JC; Sigaux F; Weiss EH; Pla M J Immunol; 1999 May; 162(9):5190-6. PubMed ID: 10227992 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the HLA-Cw3-specific cytotoxic T lymphocyte response of HLA-B7 X human beta 2m double transgenic mice. Barra C; Pérarnau B; Gerlinger P; Lemeur M; Gillet A; Gibier P; Lemonnier FA J Immunol; 1989 Nov; 143(10):3117-24. PubMed ID: 2478616 [TBL] [Abstract][Full Text] [Related]
4. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells. Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902 [TBL] [Abstract][Full Text] [Related]
5. Specificity and frequency of primary anti-HLA cytotoxic T lymphocytes in normal and HLA-B27.2-, HLA-B27.5-, and HLA-Cw3-transgenic mice. A transgenic model for MHC xenoantigen recognition. Kievits F; Boerenkamp WJ; Lokhorst W; Ivanyi P J Immunol; 1990 Jun; 144(12):4513-9. PubMed ID: 2351823 [TBL] [Abstract][Full Text] [Related]
7. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection. Tishon A; LaFace DM; Lewicki H; van Binnendijk RS; Osterhaus A; Oldstone MB Virology; 2000 Sep; 275(2):286-93. PubMed ID: 10998329 [TBL] [Abstract][Full Text] [Related]
8. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. Kingsbury DJ; Mear JP; Witte DP; Taurog JD; Roopenian DC; Colbert RA Arthritis Rheum; 2000 Oct; 43(10):2290-6. PubMed ID: 11037889 [TBL] [Abstract][Full Text] [Related]
9. Cell surface expression and alloantigenic function of a human class I MHC heavy chain gene (HLA-B7) in transgenic mice. Chamberlain JW; Nolan JA; Gromkowski SH; Kelley KA; Eisenstadt JM; Herrup K; Janeway CA; Weissman SM J Immunol; 1988 Feb; 140(4):1285-92. PubMed ID: 3125253 [TBL] [Abstract][Full Text] [Related]
10. [Immunological function of HLA-DQw6 molecules expressed in DQw6 transgenic C57BL/6 mice]. Inamitsu T Fukuoka Igaku Zasshi; 1991 Feb; 82(2):59-70. PubMed ID: 2022362 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element. Le AX; Bernhard EJ; Holterman MJ; Strub S; Parham P; Lacy E; Engelhard VH J Immunol; 1989 Feb; 142(4):1366-71. PubMed ID: 2464645 [TBL] [Abstract][Full Text] [Related]
12. Expression of human HLA-B27 transgene alters susceptibility to murine Theiler's virus-induced demyelination. Rodriguez M; Nickerson C; Patick AK; David CS J Immunol; 1991 Apr; 146(8):2596-602. PubMed ID: 2016520 [TBL] [Abstract][Full Text] [Related]
13. Abrogation of H-2-restricted CTL responses and efficient recognition of HLA-A3 molecules in DBA/2 HLA/A24 responder mice. Barra C; Gournier H; Garcia Z; Marche PN; Jouvin-Marche E; Briand P; Fillipi P; Lemonnier FA J Immunol; 1993 May; 150(9):3681-9. PubMed ID: 7682582 [TBL] [Abstract][Full Text] [Related]
14. Abnormal anti-viral immune response in mice is corrected in HLA-B27.2-transgenic mice. Kievits F; Lokhorst W; Ivanyi P Eur J Immunol; 1990 May; 20(5):1189-92. PubMed ID: 1694133 [TBL] [Abstract][Full Text] [Related]
15. Strong xenogeneic HLA response in transgenic mice after introducing an alpha 3 domain into HLA B27. Kalinke U; Arnold B; Hämmerling GJ Nature; 1990 Dec; 348(6302):642-4. PubMed ID: 1701221 [TBL] [Abstract][Full Text] [Related]
16. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes. Galocha B; López D; López de Castro JA J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690 [TBL] [Abstract][Full Text] [Related]
17. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface. Carreno BM; Hansen TH Eur J Immunol; 1994 Jun; 24(6):1285-92. PubMed ID: 8206088 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. Khare SD; Bull MJ; Hanson J; Luthra HS; David CS J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961 [TBL] [Abstract][Full Text] [Related]
20. Recognition of chlamydial antigen by HLA-B27-restricted cytotoxic T cells in HLA-B*2705 transgenic CBA (H-2k) mice. Kuon W; Lauster R; Böttcher U; Koroknay A; Ulbrecht M; Hartmann M; Grolms M; Ugrinovic S; Braun J; Weiss EH; Sieper J Arthritis Rheum; 1997 May; 40(5):945-54. PubMed ID: 9153558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]